The GENAP Summit 2027 returns as a premier platform dedicated to aseptic processing, sterile manufacturing, and Advanced Therapy Medicinal Products (ATMPs). As the pharmaceutical industry continues to evolve through automation, Annex 1 implementation, and next-generation therapies, GENAP 2027 will provide practical insights, technical case studies, and forward-looking discussions from across the global pharma and biotech sectors.
This year’s unified program will explore the intersection of aseptic manufacturing, contamination control, digitalization, and ATMP production, covering key areas such as sterility assurance, fill/finish technologies, robotics, environmental monitoring, and advanced bioprocessing strategies. Key topics include:
Aseptic Processing & Advanced Manufacturing
- Innovations in contamination control, cleanroom operations, and gloveless isolators
- Advanced fill/finish technologies and automated sterile manufacturing
- Aseptic process simulation (APS) and sterility assurance strategies
ATMPs, Viral Vectors & Bioprocessing
- Manufacturing challenges and scalability for cell & gene therapies
- Viral vector production and advanced bioprocessing strategies
- CMC considerations and flexible manufacturing approaches for ATMPs
Pharma 4.0 & Smart Manufacturing
- AI, automation, and robotics in sterile manufacturing environments
- Data-driven GMP compliance and digital transformation strategies
- Future-ready and modular pharmaceutical manufacturing facilities
Regulatory & GMP Compliance
- Annex 1 implementation and inspection readiness
- Environmental monitoring, risk management, and contamination control strategies
- Regulatory expectations for sterile manufacturing and ATMP facilities
Join us in Hamburg for two days of technical discussions, practical case studies, and high-level networking with industry leaders shaping the future of aseptic processing and advanced therapy manufacturing.
